Journal for ImmunoTherapy of Cancer (Nov 2020)
433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial
- Min Yi,
- Celeste Lebbe,
- Parminder Singh,
- Omid Hamid,
- Jason Chesney,
- Igor Puzanov,
- Mohammed Milhem,
- Merrick Ross,
- Janice Mehnert,
- Theodore Logan,
- Philip Friedlander,
- Frances Collichio,
- Claus Garbe,
- John Glaspy,
- Axel Hauschild,
- Wendy Snyder
Affiliations
- Min Yi
- 1 Department of Epidemiology, School of Public Health, Nantong University, Nantong, China
- Celeste Lebbe
- 3 Service de Dermatologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Paris, France
- Parminder Singh
- Medicine, Imperial College London, London, UK
- Omid Hamid
- 6Angeles Clinic and Research Institute, Los Angeles, CA, USA
- Jason Chesney
- Aff5 grid.266623.50000000121131622University of Louisville Louisville KY USA
- Igor Puzanov
- 9Roswell Park Cancer Institute, Buffalo, NY, USA
- Mohammed Milhem
- Aff10 grid.214572.70000000419368294University of Iowa Iowa City IA USA
- Merrick Ross
- Aff6 grid.240145.60000000122914776MD Anderson Cancer Center Houston TX USA
- Janice Mehnert
- 6Perlmutter Cancer Center at NYU Langone, New York, NY, USA
- Theodore Logan
- Aff33 grid.411377.7000000010790959XSimon Cancer CenterIndiana University Indianapolis IN USA
- Philip Friedlander
- Aff222 grid.59734.3c0000000106702351Icahn School of Medicine at Mount Sinai New York NY USA
- Frances Collichio
- Aff2 0000 0001 1034 1720grid.410711.2University of North Carolina Medical Center Chapel Hill NC USA
- Claus Garbe
- Aff1 0000 0001 0196 8249grid.411544.1Center for Dermatooncology, Department of DermatologyUniversity Hospital Tuebingen Liebermeisterstr. 25 72076 Tuebingen Germany
- John Glaspy
- Aff5 grid.19006.3e0000000096326718UCLA Jonsson Comprehesive Cancer Center Los Angeles CA USA
- Axel Hauschild
- 11 Department of Dermatology, University Hospital (UKSH), Kiel, Germany
- Wendy Snyder
- 14Amgen Inc., Thousand Oaks, CA, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0433
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.